[Anemia in candidates for heart surgery]

Area of Science:

• Cardiology
• Hematology
• Surgical Medicine

Background:

• Anemia is prevalent in cardiac surgery patients, increasing morbidity, mortality, and transfusion requirements.
• Iron deficiency is a common, correctable cause of anemia in this population.
• Preoperative anemia management is critical but time-constrained.

Purpose of the Study:

• To review current therapeutic strategies for correcting iron deficiency anemia in patients undergoing heart surgery.
• To highlight the variability in treatment regimens and the need for optimized protocols.

Main Methods:

• Review of existing studies on iron deficiency replenishment and erythropoiesis-stimulating agents in cardiac surgery patients.
• Analysis of different dosages, routes, drug combinations, and reported outcomes.

Main Results:

• Therapeutic regimens involving iron and erythropoiesis-stimulating agents can rapidly correct anemia and reduce transfusions.
• Significant variability exists in treatment protocols, including dosage, administration, and drug combinations.
• Adverse effects and specific outcomes differ across various regimens.

Conclusions:

• Optimizing anemia management in heart surgery patients requires further investigation into ideal therapeutic regimens.
• Standardized, evidence-based protocols are needed to improve patient outcomes and resource utilization.